A citation-based method for searching scientific literature

Charalampos I Liakos, Dimitrios P Papadopoulos, Elias A Sanidas, Maria I Markou, Erifili E Hatziagelaki, Charalampos A Grassos, Maria L Velliou, John D Barbetseas. Am J Cardiovasc Drugs 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hari Hendarto, Toyoshi Inoguchi, Yasutaka Maeda, Noriko Ikeda, Jing Zheng, Ryoko Takei, Hisashi Yokomizo, Eiichi Hirata, Noriyuki Sonoda, Ryoichi Takayanagi. Metabolism 2012
137
100

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Xiaokun Ding, Neeraj K Saxena, Songbai Lin, Nitika Arora Gupta, Frank A Anania. Hepatology 2006
378
100

Diabetes and Hypertension: A Position Statement by the American Diabetes Association.
Ian H de Boer, Sripal Bangalore, Athanase Benetos, Andrew M Davis, Erin D Michos, Paul Muntner, Peter Rossing, Sophia Zoungas, George Bakris. Diabetes Care 2017
205
100

DPP-4 inhibitors.
Bo Ahrén. Best Pract Res Clin Endocrinol Metab 2007
116
100

Arterial stiffness in diabetes mellitus.
Stuart B Prenner, Julio A Chirinos. Atherosclerosis 2015
140
100

Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages.
C Guo, T Huang, A Chen, X Chen, L Wang, F Shen, X Gu. Braz J Med Biol Res 2016
29
100

The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review.
Habib Yaribeygi, Yunes Panahi, Behjat Javadi, Amirhossein Sahebkar. CNS Neurol Disord Drug Targets 2018
48
100

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
B Wang, J Zhong, H Lin, Z Zhao, Z Yan, H He, Y Ni, D Liu, Z Zhu. Diabetes Obes Metab 2013
125
100

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
100


Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
Julie A Lovshin, Annette Barnie, Ariana DeAlmeida, Alexander Logan, Bernard Zinman, Daniel J Drucker. Diabetes Care 2015
99
100

Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Limei Liu, Jian Liu, Wing Tak Wong, Xiao Yu Tian, Chi Wai Lau, Yi-Xiang Wang, Gang Xu, Yunfei Pu, Zhiming Zhu, Aimin Xu,[...]. Hypertension 2012
134
100

Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway.
Jianhui Liu, Fei Yin, Xuxu Zheng, Jiajia Jing, Yinhe Hu. Neurochem Int 2007
117
100


Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.
Alan Garber, Robert Henry, Robert Ratner, Pedro A Garcia-Hernandez, Hiromi Rodriguez-Pattzi, Israel Olvera-Alvarez, Paula M Hale, Milan Zdravkovic, Bruce Bode. Lancet 2009
765
100



Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways.
Mei-Yueh Lee, Kun-Bow Tsai, Jong-Hau Hsu, Shyi-Jang Shin, Jiunn-Ren Wu, Jwu-Lai Yeh. Sci Rep 2016
32
100

Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection.
Amanda N Long, Samuel Dagogo-Jack. J Clin Hypertens (Greenwich) 2011
167
100

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats.
Que Liu, Lisa Adams, Anatoly Broyde, Rayne Fernandez, Alain D Baron, David G Parkes. Cardiovasc Diabetol 2010
53
100




GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress.
Yaojing Jiang, Zhihong Wang, Bo Ma, Linling Fan, Na Yi, Bin Lu, Qinghua Wang, Rui Liu. Front Pharmacol 2018
10
100

Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism.
Weidong Chai, Zhenhua Dong, Nasui Wang, Wenhui Wang, Lijian Tao, Wenhong Cao, Zhenqi Liu. Diabetes 2012
123
100

GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side.
Brad P Dieter, Radica Z Alicic, Katherine R Tuttle. Am J Physiol Renal Physiol 2018
19
100

Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults.
Katherine S O'Neal, Jeremy L Johnson, Rebekah L Panak. Diabetes Spectr 2016
18
100

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Fiona Turnbull, Bruce Neal, Charles Algert, John Chalmers, Neil Chapman, Jeff Cutler, Mark Woodward, Stephen MacMahon. Arch Intern Med 2005
544
100

57
100


Neuromodulatory effects of anti-diabetes medications: A mechanistic review.
Habib Yaribeygi, Milad Ashrafizadeh, Neil C Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Pharmacol Res 2020
8
100

Incretin-based therapies and renin-angiotensin system: Looking for new therapeutic potentials in the diabetic milieu.
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Life Sci 2020
5
100

Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.
Luciana Neves Cosenso-Martin, Luiz Tadeu Giollo-Júnior, Letícia Aparecida Barufi Fernandes, Cláudia Bernardi Cesarino, Marcelo Arruda Nakazone, Maurício de Nassau Machado, Juan Carlos Yugar-Toledo, José Fernando Vilela-Martin. Acta Diabetol 2018
8
100

Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release.
Tania Romacho, Susana Vallejo, Laura A Villalobos, Nina Wronkowitz, Ira Indrakusuma, Henrike Sell, Jüergen Eckel, Carlos F Sánchez-Ferrer, Concepción Peiró. J Hypertens 2016
27
100


GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.
Kathleen J Griffioen, Ruiqian Wan, Eitan Okun, Xin Wang, Mary Rachael Lovett-Barr, Yazhou Li, Mohamed R Mughal, David Mendelowitz, Mark P Mattson. Cardiovasc Res 2011
69
100


Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level.
Nadine Kuniss, Michael Freyer, Nicolle Müller, Volker Kielstein, Ulrich A Müller. Acta Diabetol 2019
8
100

Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.
R Preston Mason, Robert F Jacob, Ruslan Kubant, Aleksander Ciszewski, J Jose Corbalan, Tadeusz Malinski. J Cardiovasc Pharmacol 2012
56
100

Hypertension with diabetes mellitus complications.
Daisuke Yamazaki, Hirofumi Hitomi, Akira Nishiyama. Hypertens Res 2018
27
100

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.
Aya Shiraki, Jun-ichi Oyama, Hiroshi Komoda, Machiko Asaka, Aiko Komatsu, Masashi Sakuma, Kazuhisa Kodama, Yoshiko Sakamoto, Norihiko Kotooka, Tetsuaki Hirase,[...]. Atherosclerosis 2012
165
100

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
768
100

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
J Buteau, S Foisy, C J Rhodes, L Carpenter, T J Biden, M Prentki. Diabetes 2001
192
100

Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
Amin Al-Awar, Nikoletta Almási, Renáta Szabó, Istvan Takacs, Zsolt Murlasits, Gergő Szűcs, Szilvia Török, Anikó Pósa, Csaba Varga, Krisztina Kupai. Int J Mol Sci 2018
11
100

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.
A R Meloni, M B DeYoung, C Lowe, D G Parkes. Diabetes Obes Metab 2013
156
100

Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.
Caroline Pereira Domingueti, Luci Maria Sant'Ana Dusse, Maria das Graças Carvalho, Lirlândia Pires de Sousa, Karina Braga Gomes, Ana Paula Fernandes. J Diabetes Complications 2016
256
100

Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids.
Denise Wootten, John Simms, Cassandra Koole, Owen L Woodman, Roger J Summers, Arthur Christopoulos, Patrick M Sexton. J Pharmacol Exp Ther 2011
48
100

Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans.
C N Andrews, A E Bharucha, M Camilleri, P A Low, B M Seide, D D Burton, K K Nickander, K L Baxter, A R Zinsmeister. Neurogastroenterol Motil 2007
16
100

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
Elizabeth J Mayer-Davis, Jean M Lawrence, Dana Dabelea, Jasmin Divers, Scott Isom, Lawrence Dolan, Giuseppina Imperatore, Barbara Linder, Santica Marcovina, David J Pettitt,[...]. N Engl J Med 2017
551
100

DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition.
Scott A Hubers, Jessica R Wilson, Chang Yu, Hui Nian, Eric Grouzmann, Philippe Eugster, Cyndya A Shibao, Frederic T Billings, Scott Jafarian Kerman, Nancy J Brown. Hypertension 2018
15
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.